Psilocybin mushrooms are going mainstream, but scientific research and regulation lag behind
Psilocybin falls into a regulatory gray zone, with strict limitations around how it can be studied. As a result, very little is known about its health risks, despite its surging popularity.
April 09, 2026
Amazon unveils new AI warehouse robot in $12 billion Europe push
Melinda French Gates donates $215 million to improve women's health worldwide
A fire at a nursing home in Sri Lanka has killed 12 people, police say
Sherpa rescued after going missing on Everest with no food, oxygen
Lebanese President says ceasefire may come into effect within a day of parties' approval
European shares steady as investors eye Mideast tensions; Remy gains
Iran players describe how the war affects their World Cup preparations
Serbia's security agency advises Vucic not to travel to EU summit in Montenegro